Opinion: Inhibition of Blood-Brain Barrier Repair As a Mechanism in HIV-1 Disease

Overview

Journal Front Neurosci

Date 2017 May 12

PMID 28491017

Citations 2

Authors

Monique E Maubert

Brian Wigdahl

Michael R Nonnemacher

Affiliations

Soon will be listed here.

Citing Articles

Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis.

Rani A, Ergun S, Karnati S, Jha H J Neurovirol. 2024; 30(1):22-38.

PMID: 38189894 DOI: 10.1007/s13365-023-01190-8.

The Association of Immune Markers with Cognitive Performance in South African HIV-Positive Patients.

Williams M, Ipser J, Stein D, Joska J, Naude P J Neuroimmune Pharmacol. 2019; 14(4):679-687.

PMID: 31388873 DOI: 10.1007/s11481-019-09870-1.

The Role of Brain Barriers in Maintaining Brain Vitamin Levels.

Tiani K, Stover P, Field M Annu Rev Nutr. 2019; 39:147-173.

PMID: 31150592 PMC: 11791776. DOI: 10.1146/annurev-nutr-082018-124235.

References

Aiamkitsumrit B, Dampier W, Antell G, Rivera N, Martin-Garcia J, Pirrone V . Bioinformatic analysis of HIV-1 entry and pathogenesis. Curr HIV Res. 2014; 12(2):132-61. PMC: 4382797. DOI: 10.2174/1570162x12666140526121746. View

Reijerkerk A, Kooij G, van der Pol S, Leyen T, Lakeman K, van Het Hof B . The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier. J Neurochem. 2010; 113(2):447-53. DOI: 10.1111/j.1471-4159.2010.06598.x. View

Lee C, Lu W, Michel J, Goehring A, Du J, Song X . NMDA receptor structures reveal subunit arrangement and pore architecture. Nature. 2014; 511(7508):191-7. PMC: 4263351. DOI: 10.1038/nature13548. View

He H, Venema V, Gu X, Venema R, Marrero M, Caldwell R . Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem. 1999; 274(35):25130-5. DOI: 10.1074/jbc.274.35.25130. View

Chun R, Semmes O, Neuveut C, Jeang K . Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J Virol. 1998; 72(4):2615-29. PMC: 109697. DOI: 10.1128/JVI.72.4.2615-2629.1998. View

James T, Nonnemacher M, Wigdahl B, Krebs F . Defining the roles for Vpr in HIV-1-associated neuropathogenesis. J Neurovirol. 2016; 22(4):403-15. PMC: 5144576. DOI: 10.1007/s13365-016-0436-5. View

Toborek M, Lee Y, Flora G, Pu H, Andras I, Wylegala E . Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol. 2005; 25(1):181-99. PMC: 11529531. DOI: 10.1007/s10571-004-1383-x. View

Cao H, Zheng L, Wang N, Wang L, Li Y, Li D . Src blockage by siRNA inhibits VEGF-induced vascular hyperpemeability and osteoclast activity - an in vitro mechanism study for preventing destructive repair of osteonecrosis. Bone. 2015; 74:58-68. DOI: 10.1016/j.bone.2014.12.060. View

Zhang X, Lanahan A, Simons M . VEGFR2 trafficking: speed doesn't kill. Cell Cycle. 2013; 12(14):2163-4. PMC: 3755059. DOI: 10.4161/cc.25536. View

10.

Wang D, Melancon J, Verbesey J, Hu H, Liu C, Aslam S . Microvascular Endothelial Dysfunction and Enhanced Thromboxane and Endothelial Contractility in Patients with HIV. J AIDS Clin Res. 2014; 4(12):267. PMC: 4066983. DOI: 10.4172/2155-6113.1000267. View

11.

Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori M, Visco-Comandini U . Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr. 2007; 45(2):174-82. DOI: 10.1097/QAI.0b013e318042e1ee. View

12.

Burnett J, Miller-Jensen K, Shah P, Arkin A, Schaffer D . Control of stochastic gene expression by host factors at the HIV promoter. PLoS Pathog. 2009; 5(1):e1000260. PMC: 2607019. DOI: 10.1371/journal.ppat.1000260. View

13.

Boggon T, Eck M . Structure and regulation of Src family kinases. Oncogene. 2004; 23(48):7918-27. DOI: 10.1038/sj.onc.1208081. View

14.

Logsdon A, Lucke-Wold B, Turner R, Huber J, Rosen C, Simpkins J . Role of Microvascular Disruption in Brain Damage from Traumatic Brain Injury. Compr Physiol. 2015; 5(3):1147-60. PMC: 4573402. DOI: 10.1002/cphy.c140057. View

15.

Pittaluga A, Pattarini R, Severi P, Raiteri M . Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS. 1996; 10(5):463-8. DOI: 10.1097/00002030-199605000-00003. View

16.

Song L, Nath A, Geiger J, Moore A, Hochman S . Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site. J Neurovirol. 2003; 9(3):399-403. DOI: 10.1080/13550280390201704. View

17.

Ferrucci A, Nonnemacher M, Wigdahl B . Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis. Adv Virus Res. 2011; 81:165-99. PMC: 3731056. DOI: 10.1016/B978-0-12-385885-6.00010-9. View

18.

Lu W, Xiong Z, Lei S, Orser B, Dudek E, Browning M . G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci. 1999; 2(4):331-8. DOI: 10.1038/7243. View

19.

Obermeit L, Beltran J, Casaletto K, Franklin D, Letendre S, Ellis R . Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND. J Neurovirol. 2016; 23(1):67-78. PMC: 5325815. DOI: 10.1007/s13365-016-0474-z. View

20.

Mitola S, Soldi R, Zanon I, Barra L, Gutierrez M, Berkhout B . Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. J Virol. 1999; 74(1):344-53. PMC: 111545. DOI: 10.1128/jvi.74.1.344-353.2000. View